name,category,termsATPase, Ca++ transporting, plasma membrane 1,INTERPRO[450001556$IPR001757:ATPase, P-type, K/Mg/Cd/Cu/Zn/Na/Ca/Na/H-transporter, 450003534$IPR004014:ATPase, P-type cation-transporter, N-terminal, 450005281$IPR005834:Haloacid dehalogenase-like hydrolase, 450005504$IPR006068:ATPase, P-type cation-transporter, C-terminal, 450005830$IPR006408:ATPase, P-type, calcium-transporting, PMCA-type, 450007545$IPR008250:ATPase, P-type, ATPase-associated region, 450016587$IPR018303:ATPase, P-type phosphorylation site]
ATPase, Ca++ transporting, plasma membrane 1,KEGG_PATHWAY[470038829$hsa04020:Calcium signaling pathway]
ATPase, Ca++ transporting, plasma membrane 1,PIR_SUPERFAMILY[630001445$PIRSF001297:Na(+)/K(+)-transporting ATPase alpha chain]
ATPase, Ca++ transporting, plasma membrane 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000134$ATP, 790000138$atp-binding, 790000211$calcium, 790000215$calcium transport, 790000218$calmodulin-binding, 790000264$cell membrane, 790000356$complete proteome, 790000743$hydrolase, 790000798$ion transport, 790000899$magnesium, 790000919$membrane, 790000937$metal-binding, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane, 790001556$transmembrane protein, 790001558$transport]
ATPase, Ca++ transporting, plasma membrane 1,UP_SEQ_FEATURE[850000003$active site:4-aspartylphosphate intermediate, 850039438$chain:Plasma membrane calcium-transporting ATPase 1, 850102572$compositionally biased region:Poly-Glu, 850106107$metal ion-binding site:Magnesium, 850106258$modified residue, 850111170$region of interest:Calmodulin-binding subdomain A, 850111171$region of interest:Calmodulin-binding subdomain B, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
C1q and tumor necrosis factor related protein 1,INTERPRO[450000941$IPR001073:Complement C1q protein, 450007490$IPR008160:Collagen triple helix repeat, 450008180$IPR008983:Tumour necrosis factor-like]
C1q and tumor necrosis factor related protein 1,SMART[760000097$SM00110:C1Q]
C1q and tumor necrosis factor related protein 1,SP_PIR_KEYWORDS[790000345$collagen, 790000356$complete proteome, 790000616$glycoprotein, 790001363$Secreted, 790001405$signal]
C1q and tumor necrosis factor related protein 1,UP_SEQ_FEATURE[850012307$chain:Complement C1q tumor necrosis factor- related protein 1, 850103196$domain:C1q, 850103389$domain:Collagen-like, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117814$signal peptide]
PTK2B protein tyrosine kinase 2 beta,BIOCARTA[30000004$h_achPathway:Role of nicotinic acetylcholine receptors in the regulation of apoptosis, 30000027$h_At1rPathway:Angiotensin II mediated activation of JNK Pathway via Pyk2 dependent signaling, 30000039$h_biopeptidesPathway:Bioactive Peptide Induced Signaling Pathway, 30000052$h_Ccr5Pathway:Pertussis toxin-insensitive CCR5 Signaling in Macrophage, 30000077$h_cxcr4Pathway:CXCR4 Signaling Pathway, 30000133$h_HBxPathway:Calcium Signaling by HBx of Hepatitis B virus, 30000161$h_il7Pathway:IL-7 Signal Transduction, 30000166$h_ionPathway:Ion Channel and Phorbal Esters Signaling Pathway, 30000186$h_metPathway:Signaling of Hepatocyte Growth Factor Receptor, 30000202$h_nkcellsPathway:Ras-Independent pathway in NK cell-mediated cytotoxicity, 30000218$h_Par1Pathway:Thrombin signaling and protease-activated receptors, 30000244$h_pyk2Pathway:Links between Pyk2 and Map Kinases]
PTK2B protein tyrosine kinase 2 beta,INTERPRO[450000257$IPR000299:FERM domain, 450000618$IPR000719:Protein kinase, core, 450001096$IPR001245:Tyrosine protein kinase, 450004653$IPR005189:Focal adhesion targeting region, 450007559$IPR008266:Tyrosine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450017984$IPR019747:FERM conserved site, 450017985$IPR019748:FERM central domain, 450017986$IPR019749:Band 4.1 domain]
PTK2B protein tyrosine kinase 2 beta,KEGG_PATHWAY[470038829$hsa04020:Calcium signaling pathway, 470038831$hsa04062:Chemokine signaling pathway, 470038868$hsa04650:Natural killer cell mediated cytotoxicity, 470038873$hsa04670:Leukocyte transendothelial migration, 470038883$hsa04912:GnRH signaling pathway]
PTK2B protein tyrosine kinase 2 beta,SMART[760000192$SM00219:TyrKc, 760000266$SM00295:B41]
PTK2B protein tyrosine kinase 2 beta,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000138$atp-binding, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000825$kinase, 790000919$membrane, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001547$transferase, 790001586$tyrosine-protein kinase]
PTK2B protein tyrosine kinase 2 beta,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850048623$chain:Protein-tyrosine kinase 2-beta, 850102586$compositionally biased region:Pro-rich, 850103760$domain:FERM, 850105086$domain:Protein kinase, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850106263$nucleotide phosphate-binding region:ATP, 850111692$region of interest:Focal adhesion targeting (FAT), 850112919$region of interest:Interaction with TGFB1I1, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
Rab interacting lysosomal protein-like 1,INTERPRO[450017389$IPR019143:JNK/Rab-associated protein-1]
Rab interacting lysosomal protein-like 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790001162$phosphoprotein]
Rab interacting lysosomal protein-like 1,UP_SEQ_FEATURE[850058153$chain:RILP-like protein 1, 850105198$domain:RILP-like, 850106258$modified residue, 850118574$splice variant]
S100 calcium binding protein A3,INTERPRO[450001551$IPR001751:S100/CaBP-9k-type, calcium binding, 450010817$IPR011992:EF-Hand type, 450012399$IPR013787:S100/CaBP-9k-type, calcium binding, subdomain, 450016532$IPR018247:EF-HAND 1]
S100 calcium binding protein A3,PIR_SUPERFAMILY[630002472$PIRSF002353:S-100 protein]
S100 calcium binding protein A3,SP_PIR_KEYWORDS[790000002$3d-structure, 790000211$calcium, 790000212$calcium binding, 790000356$complete proteome, 790000480$EF hand, 790000937$metal-binding, 790001212$polymorphism, 790001304$repeat, 790001648$zinc]
S100 calcium binding protein A3,UP_SEQ_FEATURE[850000620$calcium-binding region:1; low affinity, 850000624$calcium-binding region:2; high affinity, 850047561$chain:Protein S100-A3, 850103572$domain:EF-hand 1, 850103583$domain:EF-hand 2, 850105852$helix, 850106219$metal ion-binding site:Zinc 1, 850106226$metal ion-binding site:Zinc 2, 850117295$sequence variant, 850118575$strand, 850118624$turn]
ankyrin repeat domain 28,COG_ONTOLOGY[90000073$General function prediction only]
ankyrin repeat domain 28,INTERPRO[450001870$IPR002110:Ankyrin]
ankyrin repeat domain 28,PIR_SUPERFAMILY[630002426$PIRSF002300:syphilis spirochete probable ankyrin]
ankyrin repeat domain 28,SMART[760000220$SM00248:ANK]
ankyrin repeat domain 28,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000086$ank repeat, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001304$repeat]
ankyrin repeat domain 28,UP_SEQ_FEATURE[850060140$chain:Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A, 850106258$modified residue, 850106259$mutagenesis site, 850115632$repeat:ANK 1, 850115633$repeat:ANK 10, 850115634$repeat:ANK 11, 850115635$repeat:ANK 12, 850115636$repeat:ANK 13, 850115637$repeat:ANK 14, 850115638$repeat:ANK 15, 850115639$repeat:ANK 16, 850115640$repeat:ANK 17, 850115641$repeat:ANK 18, 850115642$repeat:ANK 19, 850115644$repeat:ANK 2, 850115645$repeat:ANK 20, 850115646$repeat:ANK 21, 850115647$repeat:ANK 22, 850115648$repeat:ANK 23, 850115649$repeat:ANK 24, 850115650$repeat:ANK 25, 850115651$repeat:ANK 26, 850115652$repeat:ANK 27, 850115654$repeat:ANK 3, 850115655$repeat:ANK 4, 850115656$repeat:ANK 5, 850115657$repeat:ANK 6, 850115658$repeat:ANK 7, 850115659$repeat:ANK 8, 850115660$repeat:ANK 9, 850117294$sequence conflict, 850118574$splice variant]
asialoglycoprotein receptor 2,INTERPRO[450001149$IPR001304:C-type lectin, 450002094$IPR002353:Type II antifreeze protein, 450005088$IPR005640:Hepatic lectin, N-terminal, 450014523$IPR016186:C-type lectin-like, 450016659$IPR018378:C-type lectin, conserved site]
asialoglycoprotein receptor 2,PIR_SUPERFAMILY[630002543$PIRSF002424:hepatic lectin]
asialoglycoprotein receptor 2,SMART[760000026$SM00034:CLECT]
asialoglycoprotein receptor 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000356$complete proteome, 790000447$disulfide bond, 790000496$Endocytosis, 790000616$glycoprotein, 790000848$Lectin, 790000881$lipoprotein, 790000885$liver, 790000919$membrane, 790001100$palmitate, 790001162$phosphoprotein, 790001301$receptor, 790001409$Signal-anchor, 790001555$transmembrane, 790001556$transmembrane protein]
asialoglycoprotein receptor 2,UP_SEQ_FEATURE[850006245$chain:Asialoglycoprotein receptor 2, 850102883$disulfide bond, 850103184$domain:C-type lectin, 850105770$glycosylation site:N-linked (GlcNAc...), 850105898$lipid moiety-binding region:S-palmitoyl cysteine, 850106258$modified residue, 850117294$sequence conflict, 850117444$short sequence motif:Endocytosis signal, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
carbohydrate (N-acetylgalactosamine 4-sulfate 6-O) sulfotransferase 15,INTERPRO[450000753$IPR000863:Sulfotransferase]
carbohydrate (N-acetylgalactosamine 4-sulfate 6-O) sulfotransferase 15,KEGG_PATHWAY[470038772$hsa00532:Chondroitin sulfate biosynthesis]
carbohydrate (N-acetylgalactosamine 4-sulfate 6-O) sulfotransferase 15,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000624$golgi apparatus, 790000919$membrane, 790001409$Signal-anchor, 790001547$transferase, 790001555$transmembrane]
carbohydrate (N-acetylgalactosamine 4-sulfate 6-O) sulfotransferase 15,UP_SEQ_FEATURE[850009410$chain:Carbohydrate sulfotransferase 15, 850105770$glycosylation site:N-linked (GlcNAc...), 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
coiled-coil domain containing 84,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790001212$polymorphism]
coiled-coil domain containing 84,UP_SEQ_FEATURE[850012061$chain:Coiled-coil domain-containing protein 84, 850102480$compositionally biased region:Cys-rich, 850117295$sequence variant]
glucocorticoid modulatory element binding protein 1,INTERPRO[450000665$IPR000770:SAND, 450009947$IPR010919:SAND-like]
glucocorticoid modulatory element binding protein 1,SMART[760000230$SM00258:SAND]
glucocorticoid modulatory element binding protein 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc]
glucocorticoid modulatory element binding protein 1,UP_SEQ_FEATURE[850000333$binding site:DNA, 850021368$chain:Glucocorticoid modulatory element-binding protein 1, 850105253$domain:SAND, 850105852$helix, 850106218$metal ion-binding site:Zinc, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
meiotic nuclear divisions 1 homolog (S. cerevisiae),COG_ONTOLOGY[90000027$Cell division and chromosome partitioning / General function prediction only]
meiotic nuclear divisions 1 homolog (S. cerevisiae),INTERPRO[450005095$IPR005647:Meiotic nuclear division protein 1]
meiotic nuclear divisions 1 homolog (S. cerevisiae),PIR_SUPERFAMILY[630020595$PIRSF026991:meiotic nuclear division protein 1, 630020596$PIRSF026991:Mnd1]
meiotic nuclear divisions 1 homolog (S. cerevisiae),SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000458$dna recombination, 790000466$dna-binding, 790000915$meiosis, 790001065$nucleus]
meiotic nuclear divisions 1 homolog (S. cerevisiae),UP_SEQ_FEATURE[850030843$chain:Meiotic nuclear division protein 1 homolog]
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila),INTERPRO[450000032$IPR000038:Cell division/GTP binding protein, 450000544$IPR000637:HMG-I and HMG-Y, DNA-binding, conserved site, 450001068$IPR001214:SET, 450001324$IPR001487:Bromodomain, 450001740$IPR001965:Zinc finger, PHD-type, 450002527$IPR002857:Zinc finger, CXXC-type, 450003176$IPR003616:Post-SET zinc-binding region, 450003413$IPR003888:FY-rich, N-terminal, 450003414$IPR003889:FY-rich, C-terminal, 450007148$IPR007797:AF-4 proto-oncoprotein, 450013919$IPR015479:Transcription factor AF4, 450014157$IPR015722:MLL Transcription Factor, 450014376$IPR015967:Zinc finger C4-type, RecR, 450014891$IPR016569:Methyltransferase, trithorax, 450016267$IPR017956:AT hook, DNA-binding, conserved site, 450016532$IPR018247:EF-HAND 1, 450016788$IPR018516:FY-rich, C-terminal subgroup, 450016790$IPR018518:FY-rich, N-terminal subgroup, 450018019$IPR019786:Zinc finger, PHD-type, conserved site, 450018020$IPR019787:Zinc finger, PHD-finger]
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila),OMIM_DISEASE[520002862$Leukemia, myeloid/lymphoid or mixed-lineage]
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila),PIR_SUPERFAMILY[630009176$PIRSF010354:Methyltransferase_trithorax, 630009177$PIRSF010354:protein methyltransferase, trithorax protein type]
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila),SMART[760000221$SM00249:PHD, 760000267$SM00297:BROMO, 760000286$SM00317:SET, 760000336$SM00384:AT_hook, 760000451$SM00508:PostSET, 760000481$SM00541:FYRN, 760000482$SM00542:FYRC]
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila),SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000021$acute lymphoblastic leukemia, 790000053$alternative splicing, 790000109$Apoptosis, 790000206$bromodomain, 790000311$chromatin regulator, 790000316$chromosomal rearrangement, 790000356$complete proteome, 790000445$direct protein sequencing, 790000466$dna-binding, 790000573$fusion protein, 790000639$gtp-binding, 790000811$isopeptide bond, 790000937$metal-binding, 790000954$methyltransferase, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001271$Proto-oncogene, 790001304$repeat, 790001348$s-adenosyl-l-methionine, 790001539$Transcription, 790001543$transcription regulation, 790001547$transferase, 790001592$ubl conjugation, 790001648$zinc, 790001649$zinc finger, 790001651$zinc-finger]
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila),UP_SEQ_FEATURE[850000532$binding site:S-adenosyl-L-methionine, 850024151$chain:Histone-lysine N-methyltransferase MLL, 850032210$chain:MLL cleavage product C180, 850032211$chain:MLL cleavage product N320, 850102393$compositionally biased region:Ala/Gly/Ser-rich, 850102573$compositionally biased region:Poly-Gly, 850102580$compositionally biased region:Poly-Pro, 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850102885$DNA-binding region:A.T hook 1, 850102888$DNA-binding region:A.T hook 2, 850102889$DNA-binding region:A.T hook 3, 850103173$domain:Bromo; divergent, 850104016$domain:FY-rich C-terminal, 850104017$domain:FY-rich N-terminal, 850105053$domain:Post-SET, 850105340$domain:SET, 850105852$helix, 850106218$metal ion-binding site:Zinc, 850106258$modified residue, 850106259$mutagenesis site, 850114570$region of interest:S-adenosyl-L-methionine binding, 850117294$sequence conflict, 850117295$sequence variant, 850117891$site:Breakpoint for translocation to form MLL- AF3P21 and MLL-CASC5 oncogenes, 850117893$site:Breakpoint for translocation to form MLL- AFF4 fusion protein, 850117896$site:Breakpoint for translocation to form MLL- CENPK oncogene, 850117899$site:Breakpoint for translocation to form MLL- FRYL fusion protein, 850117900$site:Breakpoint for translocation to form MLL- GAS7 oncogene, 850117901$site:Breakpoint for translocation to form MLL- LPP, 850117905$site:Breakpoint for translocation to form MLL- ZFYVE19 oncogene, 850118120$site:Cleavage; by TASP1, site 1, 850118121$site:Cleavage; by TASP1, site 2, 850118293$site:Important for WDR5-recognition and binding, 850118574$splice variant, 850118575$strand, 850118624$turn, 850118796$zinc finger region:CXXC-type, 850118878$zinc finger region:PHD-type 1, 850118880$zinc finger region:PHD-type 2, 850118883$zinc finger region:PHD-type 3]
neuron navigator 3; similar to neuron navigator 3,INTERPRO[450001520$IPR001715:Calponin-like actin-binding, 450003154$IPR003593:ATPase, AAA+ type, core]
neuron navigator 3; similar to neuron navigator 3,SMART[760000025$SM00033:CH, 760000335$SM00382:AAA]
neuron navigator 3; similar to neuron navigator 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000919$membrane, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
neuron navigator 3; similar to neuron navigator 3,UP_SEQ_FEATURE[850034015$chain:Neuron navigator 3, 850102570$compositionally biased region:Poly-Gln, 850102577$compositionally biased region:Poly-Lys, 850102597$compositionally biased region:Ser-rich, 850103317$domain:CH, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
potassium voltage-gated channel, KQT-like subfamily, member 2,INTERPRO[450002716$IPR003091:Voltage-dependent potassium channel, 450003462$IPR003937:Potassium channel, voltage dependent, KCNQ, 450003471$IPR003947:Potassium channel, voltage dependent, KCNQ2, 450005268$IPR005821:Ion transport, 450012425$IPR013821:Potassium channel, voltage dependent, KCNQ, C-terminal]
potassium voltage-gated channel, KQT-like subfamily, member 2,OMIM_DISEASE[520001734$Epilepsy, benign, neonatal, type 1, 520003483$Myokymia with neonatal epilepsy]
potassium voltage-gated channel, KQT-like subfamily, member 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000446$disease mutation, 790000509$epilepsy, 790000798$ion transport, 790000799$ionic channel, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001226$potassium, 790001227$potassium channel, 790001229$potassium transport, 790001555$transmembrane, 790001558$transport, 790001631$voltage-gated channel]
potassium voltage-gated channel, KQT-like subfamily, member 2,UP_SEQ_FEATURE[850040192$chain:Potassium voltage-gated channel subfamily KQT member 2, 850106258$modified residue, 850106259$mutagenesis site, 850114612$region of interest:Segment H5 (pore-forming), 850117294$sequence conflict, 850117295$sequence variant, 850117700$short sequence motif:Selectivity filter, 850118574$splice variant, 850118623$transmembrane region]
promyelocytic leukemia; similar to promyelocytic leukemia protein isoform 1,BIOCARTA[30000234$h_pmlPathway:Regulation of transcriptional activity by PML]
promyelocytic leukemia; similar to promyelocytic leukemia protein isoform 1,INTERPRO[450000269$IPR000315:Zinc finger, B-box, 450001628$IPR001841:Zinc finger, RING-type, 450016222$IPR017907:Zinc finger, RING-type, conserved site, 450016532$IPR018247:EF-HAND 1, 450017227$IPR018957:Zinc finger, C3HC4 RING-type]
promyelocytic leukemia; similar to promyelocytic leukemia protein isoform 1,KEGG_PATHWAY[470038837$hsa04120:Ubiquitin mediated proteolysis, 470038899$hsa05200:Pathways in cancer, 470038911$hsa05221:Acute myeloid leukemia]
promyelocytic leukemia; similar to promyelocytic leukemia protein isoform 1,OMIM_DISEASE[520002850$Leukemia, acute promyelocytic, PML/RARA type]
promyelocytic leukemia; similar to promyelocytic leukemia protein isoform 1,PIR_SUPERFAMILY[630012398$PIRSF015640:PML-1 protein]
promyelocytic leukemia; similar to promyelocytic leukemia protein isoform 1,SMART[760000158$SM00184:RING, 760000304$SM00336:BBOX]
promyelocytic leukemia; similar to promyelocytic leukemia protein isoform 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000020$activator, 790000053$alternative splicing, 790000316$chromosomal rearrangement, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000449$DNA binding, 790000466$dna-binding, 790000733$host-virus interaction, 790000811$isopeptide bond, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001271$Proto-oncogene, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001592$ubl conjugation, 790001648$zinc, 790001651$zinc-finger]
promyelocytic leukemia; similar to promyelocytic leukemia protein isoform 1,UP_SEQ_FEATURE[850044039$chain:Probable transcription factor PML, 850102586$compositionally biased region:Pro-rich, 850102714$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), 850106219$metal ion-binding site:Zinc 1, 850106226$metal ion-binding site:Zinc 2, 850106258$modified residue, 850106259$mutagenesis site, 850113810$region of interest:Nuclear localization signal, 850117294$sequence conflict, 850117295$sequence variant, 850117930$site:Breakpoint for translocation to form PML- RARA oncogene in type A APL, 850117931$site:Breakpoint for translocation to form PML- RARA oncogene in type B APL, 850118574$splice variant, 850118575$strand, 850118640$zinc finger region:B box-type 1; atypical, 850118642$zinc finger region:B box-type 2, 850118911$zinc finger region:RING-type]
protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase),BIOCARTA[30000110$h_fasPathway:FAS signaling pathway ( CD95 )]
protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase),INTERPRO[450000210$IPR000242:Protein-tyrosine phosphatase, receptor/non-receptor type, 450000257$IPR000299:FERM domain, 450000330$IPR000387:Dual-specific/protein-tyrosine phosphatase, conserved region, 450000331$IPR000387:Protein-tyrosine phosphatase, 450001316$IPR001478:PDZ/DHR/GLGF, 450010003$IPR011019:KIND, 450010818$IPR011993:Pleckstrin homology-type, 450010931$IPR012153:Protein-tyrosine phosphatase, non-receptor type-13, 450012944$IPR014352:FERM/acyl-CoA-binding protein, 3-helical bundle, 450014489$IPR016130:Protein-tyrosine phosphatase, active site, 450017249$IPR018979:FERM, N-terminal, 450017250$IPR018980:FERM, C-terminal PH-like domain, 450017984$IPR019747:FERM conserved site, 450017985$IPR019748:FERM central domain, 450017986$IPR019749:Band 4.1 domain, 450017987$IPR019750:Band 4.1 subgroup]
protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase),PIR_SUPERFAMILY[630001080$PIRSF000933:non-receptor tyrosine-protein phosphatase, type 13, 630001081$PIRSF000933:Tyr-Ptase_nr13]
protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase),SMART[760000168$SM00194:PTPc, 760000200$SM00228:PDZ, 760000266$SM00295:B41, 760000656$SM00750:KIND]
protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000743$hydrolase, 790001162$phosphoprotein, 790001164$phosphoric monoester hydrolase, 790001212$polymorphism, 790001261$protein phosphatase, 790001301$receptor, 790001304$repeat, 790001587$tyrosine-specific phosphatase]
protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase),UP_SEQ_FEATURE[850000106$active site:Phosphocysteine intermediate, 850067649$chain:Tyrosine-protein phosphatase non-receptor type 13, 850102576$compositionally biased region:Poly-Leu, 850102581$compositionally biased region:Poly-Ser, 850103760$domain:FERM, 850104540$domain:KIND, 850104919$domain:PDZ 1, 850104924$domain:PDZ 2, 850104925$domain:PDZ 3, 850104926$domain:PDZ 4, 850104927$domain:PDZ 5, 850105593$domain:Tyrosine-protein phosphatase, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
sestrin 2,INTERPRO[450006137$IPR006730:PA26 p53-induced protein (sestrin)]
sestrin 2,KEGG_PATHWAY[470038836$hsa04115:p53 signaling pathway]
sestrin 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
sestrin 2,UP_SEQ_FEATURE[850060442$chain:Sestrin-2, 850117295$sequence variant]
zinc finger protein 3,COG_ONTOLOGY[90000073$General function prediction only]
zinc finger protein 3,INTERPRO[450001691$IPR001909:Krueppel-associated  box, 450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger protein 3,SMART[760000317$SM00349:KRAB, 760000323$SM00355:ZnF_C2H2]
zinc finger protein 3,SP_PIR_KEYWORDS[790000020$activator, 790000356$complete proteome, 790000428$developmental protein, 790000434$differentiation, 790000449$DNA binding, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001649$zinc finger, 790001651$zinc-finger]
zinc finger protein 3,UP_SEQ_FEATURE[850101558$chain:Zinc finger protein 3, 850104552$domain:KRAB, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118656$zinc finger region:C2H2-type 1, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5, 850118728$zinc finger region:C2H2-type 6, 850118731$zinc finger region:C2H2-type 7, 850118734$zinc finger region:C2H2-type 8]
zinc finger protein 74,COG_ONTOLOGY[90000073$General function prediction only]
zinc finger protein 74,INTERPRO[450001691$IPR001909:Krueppel-associated  box, 450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger protein 74,SMART[760000317$SM00349:KRAB, 760000323$SM00355:ZnF_C2H2]
zinc finger protein 74,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat, 790001339$rna-binding, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
zinc finger protein 74,UP_SEQ_FEATURE[850101889$chain:Zinc finger protein 74, 850104552$domain:KRAB, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118656$zinc finger region:C2H2-type 1, 850118657$zinc finger region:C2H2-type 10, 850118660$zinc finger region:C2H2-type 11, 850118663$zinc finger region:C2H2-type 12, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5, 850118728$zinc finger region:C2H2-type 6, 850118731$zinc finger region:C2H2-type 7, 850118734$zinc finger region:C2H2-type 8, 850118737$zinc finger region:C2H2-type 9]
